Mifepristone NDC 43393-001

NDC codes

FDA NDC Directory

Product NDC (as listed)43393-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43393-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43393-001-06	43393000106	6 CARTON in 1 PACKAGE (43393-001-06) / 1 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK (43393-001-01)Marketed from May 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mifepristone
Generic name (nonproprietary): mifepristone
Active ingredients: Mifepristone — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: GenBioPro, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091178
Marketing start: May 1, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Progestational Hormone Receptor Antagonists (Mechanism)
Identifiers: Product ID 43393-001_539725c1-189c-1934-e063-6294a90ac3c0SPL ID 539725c1-189c-1934-e063-6294a90ac3c0SPL set ID b63fad9b-7f12-4400-9019-b0586054e534RxCUI 311704UNII 320T6RNW1FUPC 0343393001019
Pharmacologic class: Progestin Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443393000106 followed by a unit qualifier and the quantity

Package 43393-0001-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 6, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Mifepristone tablets, 200 mg is indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation. Mifepristone tablets, 200 mg is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)